Sleep Disruption and Alzheimer’s Risk
Current understanding
Sleep disruption is repeatedly associated with amyloid/tau accumulation and impaired glymphatic clearance in observational and mechanistic work [human-observational, mechanism-plausible], but causal direction is unresolved because early neurodegeneration itself disturbs sleep. Emerging reviews frame muscle-metabolic status (sarcopenia, sarcopenic obesity, insulin resistance) as potential effect modifiers that may lower the threshold at which poor sleep translates into AD pathology [expert-opinion], with irisin/FNDC5–BDNF proposed as one candidate mediator [mechanism-plausible].
Evidence log
- 2026-08-18 — The nutrition-sleep-circadian axis in age-related neurodegeneration: Cellular mechanisms, metabolic dysfunction, and neuroprotective interventions.: 2024 integrative review positions sleep/circadian disruption as one arm of a nutrition–sleep–circadian axis accelerating AD/PD pathology via mitochondrial, neuroinflammatory, proteostatic, and gut–brain mechanisms — mechanistic synthesis, no new causal evidence. [expert-opinion] (novelty: 3)